4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-031276
Chief Technology Officer sold 20,000 shares at $7.19 ($143,800)
- Chief Technology Officer gave up 2,684 shares (to pay taxes)
- Chief Technology Officer acquired 6,889 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2023-05-18 | Option exercise 10b5-1 | +1,981 | 7,888,034 | D | ||
| Yan Ming Chief Technology Officer | 2023-05-18 | Shares withheld for taxes 10b5-1 | −772 | $6.69 | $5,165 | 7,887,262 | D |
| Yan Ming Chief Technology Officer | 2023-05-18 | Option exercise 10b5-1 | +4,908 | 7,892,170 | D | ||
| Yan Ming Chief Technology Officer | 2023-05-18 | Shares withheld for taxes 10b5-1 | −1,912 | $6.69 | $12,791 | 7,890,258 | D |
| Yan Ming Chief Technology Officer | 2023-05-19 | Sale 10b5-1 | −20,000 | $7.19 | $143,800 | 7,870,258 | D |
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2023-05-18 | Option exercise · Restricted Stock Units 10b5-1 | −1,981 | 21,142 | D | ||
| Yan Ming Chief Technology Officer | 2023-05-18 | Option exercise · Restricted Stock Units 10b5-1 | −4,908 | 112,905 | D | ||
| Open-market sales · 20,000 sh · avg $7.19 · $143,800 | |||||||
Loading xslF345X04/doc4.xml…